Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model.

Pitman RJ, Nagy LD, Sculpher MJ.

Vaccine. 2013 Jan 30;31(6):927-42. doi: 10.1016/j.vaccine.2012.12.010. Epub 2012 Dec 14.

2.

Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.

Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dunham KM, Meltzer MI.

PLoS One. 2011;6(7):e22308. doi: 10.1371/journal.pone.0022308. Epub 2011 Jul 29.

3.

Health and economic impact of the seasonal influenza vaccination programme in England.

Baguelin M, Jit M, Miller E, Edmunds WJ.

Vaccine. 2012 May 14;30(23):3459-62. doi: 10.1016/j.vaccine.2012.03.019. Epub 2012 Mar 22.

PMID:
22446636
4.

The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales.

Jit M, Cromer D, Baguelin M, Stowe J, Andrews N, Miller E.

Vaccine. 2010 Dec 10;29(1):115-22. doi: 10.1016/j.vaccine.2010.08.078. Epub 2010 Nov 4.

PMID:
21055501
5.

Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.

Baguelin M, Camacho A, Flasche S, Edmunds WJ.

BMC Med. 2015 Oct 13;13:236. doi: 10.1186/s12916-015-0452-y.

6.

Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales.

Pitman RJ, White LJ, Sculpher M.

Vaccine. 2012 Feb 1;30(6):1208-24. doi: 10.1016/j.vaccine.2011.11.106. Epub 2011 Dec 13.

7.

The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.

Aballéa S, De Juanes JR, Barbieri M, Martin M, Chancellor J, Oyagüez I, Verwee B, Largeron N.

Vaccine. 2007 Sep 28;25(39-40):6900-10. Epub 2007 Aug 6.

PMID:
17764790
8.

Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.

Lugnér AK, van Boven M, de Vries R, Postma MJ, Wallinga J.

BMJ. 2012 Jul 12;345:e4445. doi: 10.1136/bmj.e4445.

9.

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.

Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ.

Vaccine. 2010 Mar 11;28(12):2370-84. doi: 10.1016/j.vaccine.2010.01.002. Epub 2010 Jan 21.

PMID:
20096762
10.

Cost-effectiveness of influenza vaccination in working-age cancer patients.

Avritscher EB, Cooksley CD, Geraci JM, Bekele BN, Cantor SB, Rolston KV, Elting LS.

Cancer. 2007 Jun 1;109(11):2357-64.

11.

Public health and economic benefits of new pediatric influenza vaccination programs in Argentina.

Giglio N, Gentile A, Lees L, Micone P, Armoni J, Reygrobellet C, Crépey P.

Hum Vaccin Immunother. 2012 Mar;8(3):312-22. doi: 10.4161/hv.18569. Epub 2012 Feb 14.

12.

Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.

Clements KM, Chancellor J, Nichol K, DeLong K, Thompson D.

Value Health. 2011 Sep-Oct;14(6):800-11. doi: 10.1016/j.jval.2011.03.005.

13.

The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.

Newall AT, Scuffham PA, Kelly H, Harsley S, Macintyre CR.

Vaccine. 2008 Apr 16;26(17):2142-53. doi: 10.1016/j.vaccine.2008.01.050. Epub 2008 Feb 20.

PMID:
18343537
14.

Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.

Yang MC, Tan EC, Su JJ.

Hum Vaccin Immunother. 2017 Jan 2;13(1):81-89. doi: 10.1080/21645515.2016.1225636. Epub 2016 Sep 13.

15.

Estimating the impact of childhood influenza vaccination programmes in England and Wales.

Vynnycky E, Pitman R, Siddiqui R, Gay N, Edmunds WJ.

Vaccine. 2008 Sep 26;26(41):5321-30. doi: 10.1016/j.vaccine.2008.06.101. Epub 2008 Jul 21.

PMID:
18647634
16.

Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.

Melegaro A, Edmunds WJ.

Vaccine. 2004 Oct 22;22(31-32):4203-14.

PMID:
15474710
17.

Cost-effectiveness of influenza vaccination of healthy children.

Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T.

Vaccine. 2006 Jun 5;24(23):4934-41. Epub 2006 Apr 7.

PMID:
16678945
18.

Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.

Nichol KL.

Vaccine. 2011 Oct 6;29(43):7554-8. doi: 10.1016/j.vaccine.2011.08.015. Epub 2011 Aug 4. Review.

PMID:
21820477
19.

Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: results are inconclusive.

Mogasale V, Barendregt J.

Aust N Z J Public Health. 2011 Apr;35(2):180-6. doi: 10.1111/j.1753-6405.2010.00639.x. Epub 2010 Dec 9.

PMID:
21463417
20.

The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.

Aballéa S, Chancellor J, Martin M, Wutzler P, Carrat F, Gasparini R, Toniolo-Neto J, Drummond M, Weinstein M.

Value Health. 2007 Mar-Apr;10(2):98-116.

Supplemental Content

Support Center